Page last updated: 2024-08-18

pyrroles and B-Cell Leukemia

pyrroles has been researched along with B-Cell Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amato, R; Fallacara, AL; Giacchello, I; Greco, C; Musumeci, F; Sanna, M; Schenone, S1
Al-Harbi, S; Almasan, A; Choudhary, GS; Mazumder, S1

Reviews

1 review(s) available for pyrroles and B-Cell Leukemia

ArticleYear
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.
    Expert opinion on therapeutic patents, 2017, Volume: 27, Issue:12

    Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Autoimmune Diseases; Drug Design; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Patents as Topic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles

2017

Other Studies

1 other study(ies) available for pyrroles and B-Cell Leukemia

ArticleYear
Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells.
    Cancer research, 2012, Jun-15, Volume: 72, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Gossypol; Humans; Indoles; Leukemia, B-Cell; Membrane Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Phosphorylation; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrroles; RNA Interference; RNA, Small Interfering; Sulfonamides

2012